Monoamine Oxidase Inhibitors (MAOIs) are a class of drugs that prevent the breakdown of monoamine neurotransmitters, thereby increasing their availability in the brain. They are primarily used in the treatment of depression and anxiety disorders, but require dietary restrictions to avoid potentially dangerous interactions.